Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES CorpNMTC · Entity 7808 | Director | April 03, 2026 | April 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEUROONE MEDICAL TECHNOLOGIES Corp
Report date April 03, 2026 · Filed April 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 49,687 |
Reported balance
After 2026-04-03 transaction · row 1
1 source rowRow 1 · 2026-04-03 · Grant · Acquired 41,929 · Balance 49,687 F1: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.80 · Expires 2036-04-02 | Direct | 26,036 |
Reported balance
After 2026-04-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-03 · Grant · Acquired 26,036 · Balance 26,036 F2: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.
F2: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2026 Filed Apr 7, 2026 17:46 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 26,036 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0002103204-26-000005 · primary_doc.xml · derivative · entry 2 Mills Jason Richard · CIK 0002103204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,036 Underlying: Common Stock · 26,036 shares Expires 2036-04-02 F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| April 03, 2026 Filed Apr 7, 2026 17:46 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantCommon Stock | 41,929 | $0.00 | $0.00 |
DisclosureSEC source: 0002103204-26-000005 · primary_doc.xml · nonDerivative · entry 1 Mills Jason Richard · CIK 0002103204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,687 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| December 18, 2025 Filed Jan 2, 2026 17:03 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to purchase common stock · Derivative | 4,806 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0002103204-26-000002 · primary_doc.xml · derivative · entry 2 Mills Jason Richard · CIK 0002103204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,806 Underlying: Common Stock · 4,806 shares Expires 2035-12-18 F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| December 18, 2025 Filed Jan 2, 2026 17:03 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantCommon Stock | 7,758 | $0.00 | $0.00 |
DisclosureSEC source: 0002103204-26-000002 · primary_doc.xml · nonDerivative · entry 1 Mills Jason Richard · CIK 0002103204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,758 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.